Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib (MK-1026) – as well as KEYTRUDA® (pembrolizumab) in multiple blood cancersRAHWAY, N.J. (BUSINESS WIRE) $MRK #MRK Merck (NYSE: MRK), known as MSD outside of the United States and Ca.
01.12.2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the upcoming 64th American Society of Hematology (ASH) Annual Meeting from Dec. .
10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology .
El juez suspende la declaración de Sánchez Galán por posible indefensión lainformacion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lainformacion.com Daily Mail and Mail on Sunday newspapers.
Frustran robo en banco: antisociales fueron capturados en el techo lacuarta.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lacuarta.com Daily Mail and Mail on Sunday newspapers.